Mastologia
Comentário de estudo | Idosas com câncer de mama escolhem tratamentos menos agressivos quando usam ferramenta de auxílio à decisão.
1 Abr, 2022 | 12:40h
Comentário no Twitter
Open access in May's BJS: Bridging the age gap in breast cancer: two decision support interventions for older women with operable breast cancer https://t.co/s70uEVyAxU @AmyLightnerMD @bplwijn @des_winter @ksoreide @MalinASund @evanscolorectal @nfmkok @robhinchliffe1 @young_bjs pic.twitter.com/IUuiUldUTS
— BJS (@BJSurgery) June 11, 2021
Avaliação por inteligência artificial de 122.969 mamografias em um programa de rastreamento de base populacional.
31 Mar, 2022 | 12:50hComunicado de imprensa: AI shows potential in breast cancer screening programs – Radiological Society of North America
Metade das mulheres passam pela experiência de uma mamografia falso-positiva após 10 anos de rastreamento anual.
29 Mar, 2022 | 14:04hComunicado de imprensa: Half of all women experience false positive mammograms after 10 years of annual screening – University of California – Davis Health
Estudo original: Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography – JAMA Network Open
Comentário no Twitter
Comparative effectiveness study finds biennial screening interval, older age, and non-dense breasts were associated with larger reductions in false-positive results than screening with tomosynthesis vs digital mammography. @BCSC_research @dmiglio https://t.co/16CMFH5bcI
— JAMA Network Open (@JAMANetworkOpen) March 25, 2022
Padrões longitudinais de longo prazo da fadiga relatada pelas pacientes após câncer de mama.
23 Mar, 2022 | 11:44h
Comentário no Twitter
Congrats to @ines_vazluis, @dimeglio_anto & colleagues for another great publication from #CANTO! Here, they describe different patterns of fatigue developed after BC. Great to know that most pts (60%) fare well. We need to do better for those that don’t.https://t.co/VxxJvjECw9
— Paolo Tarantino (@PTarantinoMD) March 16, 2022
Incidência de recidiva de câncer de mama 10-32 anos após o primeiro diagnóstico.
23 Mar, 2022 | 11:34hEstudo mostra baixo risco de complicações após colocação de cateter intravenoso ipsilateral em pacientes cirúrgicas de câncer de mama.
21 Mar, 2022 | 16:26hIpsilateral Intravenous Catheter Placement in Breast Cancer Surgery Patients – Anesthesia & Analgesia (link para o resumo – $ para o texto completo)
Comentário no Twitter
🙏🙏🙏 much-needed dogmalysis. I’ve seen situations where folks were afraid to even place a Bp cuff ipsilateral to prior mastectomy. this excessive fear impairs patient care. https://t.co/afjwjjseo7
— 𝙟𝙤𝙨𝙝 𝙛𝙖𝙧𝙠𝙖𝙨 💊 (@PulmCrit) March 17, 2022
Estudo de coorte retrospectivo | Frequência e desfechos da adenopatia axilar detectada por ressonância magnética após vacinação contra COVID-19.
11 Mar, 2022 | 15:10hConteúdos relacionados:
2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients
Estudo randomizado | Sobrevida geral do câncer de mama avançado com ribociclibe e letrozol.
11 Mar, 2022 | 14:56hOverall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentários:
Adding Ribociclib to Letrozole Prolongs Survival in Advanced Breast Cancer – HealthDay
Avaliação do risco de câncer de mama para o médico da atenção primária.
10 Mar, 2022 | 15:34hBreast cancer risk evaluation for the primary care physician – Cleveland Clinic Journal of Medicine
Mapeamento de revisões sistemáticas sobre intervenções na sobrevida do câncer de mama.
10 Mar, 2022 | 15:22h
Comentário no Twitter
🌐 Despite vast volume, review-level #BreastCancer #survivorship research is unevenly distributed and siloed. Strategic planning of future research, in consultation with survivors, is needed. ➡️ https://t.co/pxMp5XK8B8 #JCO #BCSM @EmmaBKemp1 #survonc pic.twitter.com/TRjOEJQbrw
— Journal of Clinical Oncology (@JCO_ASCO) March 5, 2022